Skip to main content
Clinical Trials/NCT00844246
NCT00844246
Completed
Phase 2

Translating Evidence Based Developmental Screening Into Pediatric Primary Care ( Aims 2 and 3 )

Children's Hospital of Philadelphia4 sites in 1 country2,314 target enrollmentNovember 2008

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Developmental Delays
Sponsor
Children's Hospital of Philadelphia
Enrollment
2314
Locations
4
Primary Endpoint
The primary outcome measure for this study will be the percentage of children enrolled in the study who are identified as having a developmental delay.
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The purpose of this study is to examine the feasibility, acceptability and effectiveness of implementing the American Academy of Pediatrics (AAP's) recommendation that clinicians provide developmental surveillance at all well child visits and institute developmental screening at critical developmental periods in childhood, namely at 9, 18, 24 and 30 months of age.

Detailed Description

The purpose of this study is to examine the feasibility, acceptability and effectiveness of implementing the AAP's recommendation that clinicians provide developmental surveillance at all well child visits and institute developmental screening at critical developmental periods in childhood, namely at 9, 18, 24 and 30 months of age. The study will also examine its acceptance by pediatric practices, its adoption and adaptation in urban pediatric practices, and the effectiveness of a developmental screening protocol that conforms to the AAP and Maternal and Child Health Bureau (MCHB) recommendations compared with that of developmental surveillance alone.

Registry
clinicaltrials.gov
Start Date
November 2008
End Date
October 2010
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age birth to 30 months of age by the start of the intervention phase.
  • Child's Primary Care Physician has consented to participate in the study
  • Parental/guardian permission (informed consent).

Exclusion Criteria

  • Premature Infants (less than 36 weeks of gestation)
  • Children with prior identified developmental delay.
  • Children with major congenital anomalies/genetic disorders
  • Children placed in foster care

Outcomes

Primary Outcomes

The primary outcome measure for this study will be the percentage of children enrolled in the study who are identified as having a developmental delay.

Time Frame: We assessed this between June to October 2010

Secondary Outcomes

  • Percent of parents enrolled in the study who report as satisfied with the intervention(We assessed this between March and September 2010)
  • Percent of providers enrolled in the study who report as satisfied with the intervention.(We will assess this between March and September 2010)
  • Percentage of children in the study who enroll in Early Intervention Services(We will assess this between June to October 2010)
  • Percentage of children in the study who are referred to Early Intervention Services(We assessed this in June 2010)

Study Sites (4)

Loading locations...

Similar Trials